CID 118036971

Roblitinib

Structural Information

Molecular Formula
C25H30N8O4
SMILES
CN1CCN(C(=O)C1)CC2=C(N=C3C(=C2)CCCN3C(=O)NC4=NC=C(C(=C4)NCCOC)C#N)C=O
InChI
InChI=1S/C25H30N8O4/c1-31-7-8-32(23(35)15-31)14-18-10-17-4-3-6-33(24(17)29-21(18)16-34)25(36)30-22-11-20(27-5-9-37-2)19(12-26)13-28-22/h10-11,13,16H,3-9,14-15H2,1-2H3,(H2,27,28,30,36)
InChIKey
BHKDKKZMPODMIQ-UHFFFAOYSA-N
Compound name
N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

19
References

1376
Patents

506.239 Da
Monoisotopic Mass

0.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 507.24628 217.1
[M+Na]+ 529.22822 221.6
[M-H]- 505.23172 216.6
[M+NH4]+ 524.27282 215.4
[M+K]+ 545.20216 214.3
[M+H-H2O]+ 489.23626 196.7
[M+HCOO]- 551.23720 223.3
[M+CH3COO]- 565.25285 254.8
[M+Na-2H]- 527.21367 215.7
[M]+ 506.23845 209.4
[M]- 506.23955 209.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe